Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Dec 15, 2025
Reporting period
Not applicable
Filed with the SEC
Dec 17, 2025
CEOOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references tax withholding
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001903669-25-000010
Filed / recorded
Dec 17, 2025, 9:56 PM UTC
Added to OQRO
Oct 7, 2026, 5:52 AM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
SPRUCE BIOSCIENCES, INC.
Issuer CIK
1683553
Ticker
SPRB
Reporting person
Javier B. Szwarcberg
Relationship
Director, Officer
Officer title
CHIEF EXECUTIVE OFFICER
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Dec 15, 2025
Transaction code
M
Shares / units
1,480
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
14,478
Ownership form
Direct
Amendment
No
Footnotes from the filing
On December 5, 2022, the Reporting Person was granted 5,920 time-based restricted stock units ("RSUs"), subject to a 4-year vesting schedule, with 25% of the total number of RSUs vested on December 15, 2023 (the "Annual Vesting Date") and 25% of the total number of RSUs to vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). On December 15, 2025, 1,480 RSUs vested, with 752 shares withheld for taxes, resulting in a net issuance of 728 shares.
Each RSU represents a contingent right to receive one share of common stock of the Issuer.